OFFICAL PROJECT SITE
Novel Target for Treatment of Chronic Inflammatory Diseases — Notid
Lipum presents at Biostock Live
On August 27, Lipums CEO Einar Pontén will present our recent progress towards a novel treatment of chronic inflammatory diseases. The presentation will be broadcasted live on the web from 10am. On this autumn's first BioStock Live Investor Event you have the chance to listen to presentations and talk with [...]
Lipum invites to shareholders meeting
On August 28, Lipum shareholders will meet at Clarion Hotel Arlanda Airport. The recent progress and plans for the future will be presented and discussed. More detailed information will be sent out in personal mail. Warm welcome!
Kallelse till årsstämma i Lipum AB
Aktieägarna i Lipum AB, org. nr. 556813-5999 (“Lipum”), kallas härmed till årsstämma fredagen den 28 juni 2019, kl. 09:00 på Tvistevägen 48C i Umeå. […]
Getting roasted by investors
As a Horizon 2020 beneficiary we are invited to the SME Instrument Phase 2 Welcome Day organized by the European Innovation Council (EIC) Pilot in Brussels, May 22-23. Besides business networking the agenda includes: “Get roasted by investors – ready to go?”, “Success story from SME Instrument Innovator” and “Learn [...]
Pernilla Abrahamsson joins as Chief Operating Officer
Press release may 7, 2019 ”Lipum is a very interesting company in an exciting development. Soon in the clinical phase and I am looking forward to all challenges ahead of us”, says Pernilla Abrahamsson. […]
Umeå life science company attends world congress –
“Our product has huge potential”
Press release April 23, 2019 Umeå life science company Lipum will participate in one of the world's largest congresses for rheumatic diseases this June. “The elite of our industry gathers at this congress once a year and competition is incredibly intense. It’s important to be seen there”, says Einar Pontén, [...]
Program:
European Commission Horizon 2020
SME Instrument phase 1 No 744248
SME Instrument phase 2 No 829741
Project title:
Novel Target for Treatment of Chronic Inflammatory Diseases
Project budget:
3.2 M€
Funding from the EU:
2.2 M€
Start:
2018-11-01
End:
2020-07-31